文献速递肾移植

终末分化效应记忆CD8+ T细胞可识别肾移植失败高风险受者

Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure.
PubMed 文献 · J Am Soc Nephrol · 2020-03-12

该研究在284例肾移植受者移植后1年时检测血液CD8+ T细胞亚群频率,随访中位8.3年。结果显示TEMRA CD8+ T细胞频率升高与移植失败风险增加相关,且独立于临床变量评分;EM CD8+ T细胞频率升高则与风险降低相关。TEMRA CD8+ T细胞中CD16+亚群具有促炎和细胞毒活性,提示其参与移植排斥。

要点

  • 移植后1年TEMRA CD8+ T细胞频率升高与随访期移植失败风险增加独立相关。
  • EM CD8+ T细胞频率升高与移植失败风险降低相关。
  • CD16+ TEMRA CD8+ T细胞亚群通过TCR或CD16双途径激活,介导体液和细胞排斥。

核心结论

  • 移植后1年血液记忆CD8+ T细胞亚群组成较单独临床变量评分能更好预测8年肾移植失败。
  • TEMRA CD8+ T细胞在体液和细胞排斥中可能起关键作用。

研究设计与样本

  • 研究纳入284例肾移植受者,移植后1年采集血样,随访中位8.3年。
  • 另分析24例活体肾移植受者CD8+ T细胞对供者特异性PBMC的反应性。

主要发现

  • 移植后1年循环TEMRA CD8+ T细胞频率增加与随访期移植失败风险增加相关。
  • 该关联在调整已报道的8项临床变量复合评分(Kidney Transplant Failure Score)后仍存在。
  • EM CD8+ T细胞频率增加与移植失败风险降低相关。
  • 鉴定出表达FcγRIIIA(CD16)并高分泌促炎细胞因子、高细胞毒活性的TEMRA CD8+ T细胞亚群。
  • 供者特异性刺激诱导EM和TEMRA CD8+ T细胞相似的快速早期反应,但CD16 engagement选择性激活TEMRA CD8+ T细胞并介导抗体依赖细胞毒作用。

关键数值与推荐

  • 移植后1年TEMRA CD8+ T细胞频率升高与移植失败风险增加相关,独立于Kidney Transplant Failure Score。

临床怎么用

  • 移植后1年监测记忆CD8+ T细胞亚群可能有助于识别移植失败高风险受者。
  • TEMRA CD8+ T细胞及其CD16+亚群可作为预测排斥风险的潜在生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Identifying biomarkers to predict kidney transplant failure and to define new therapeutic targets requires more comprehensive understanding of the immune response to chronic allogeneic stimulation. METHODS: We investigated the frequency and function of CD8+ T cell subsets-including effector memory (EM) and terminally differentiated EM (TEMRA) CD8+ T cells-in blood samples from 284 kidney transplant recipients recruited 1 year post-transplant and followed for a median of 8.3 years. We also analyzed CD8+ T cell reactivity to donor-specific PBMCs in 24 patients who had received living-donor kidney transplants. RESULTS: Increased frequency of circulating TEMRA CD8+ T cells at 1 year post-transplant associated with increased risk of graft failure during follow-up. This association remained after adjustment for a previously reported composite of eight clinical variables, the Kidney Transplant Failure Score. In contrast, increased frequency of EM CD8+ T cells associated with reduced risk of graft failure. A distinct TEMRA CD8+ T cell subpopulation was identified that was characterized by expression of FcγRIIIA (CD16) and by high levels of proinflammatory cytokine secretion and cytotoxic activity. Although donor-specific stimulation induced a similar rapid, early response in EM and TEMRA CD8+ T cells, CD16 engagement resulted in selective activation of TEMRA CD8+ T cells, which mediated antibody-dependent cytotoxicity. CONCLUSIONS: At 1 year post-transplant, the composition of memory CD8+ T cell subsets in blood improved prediction of 8-year kidney transplant failure compared with a clinical-variables score alone. A subpopulation of TEMRA CD8+ T cells displays a novel dual mechanism of activation mediated by engagement of the T-cell receptor or of CD16. These findings suggest that TEMRA CD8+ T cells play a pivotal role in humoral and cellular rejection and reveal the potential value of memory CD8+ T cell monitoring for predicting risk of kidney transplant failure.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Jacquemont L, Tilly G, Yap M, et al. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. J Am Soc Nephrol. 2020. PMID: 32165419. doi:10.1681/ASN.2019080847

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。